Courtesy of Benzinga
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) announced today that Napo Pharmaceuticals, Inc. has filed a lawsuit against Salix Pharmaceuticals alleging that the Company has breached its commitments under the Collaboration Agreement between Napo and Salix concerning the development of crofelemer.
According to Company lawyers, Napo’s claims are without merit and the lawsuit is baseless. Salix intends to vigorously defend against the lawsuit and plans to continue with the development and commercialization of crofelemer in accordance with its past guidance and the terms of its Collaboration Agreement with Napo.
Visit Benzinga >